Avoid common mistakes on your manuscript.
Dear Reader,
As we approach the end of 2015, and publish our final issue of Drugs & Therapy Perspectives for the year, the editors and production staff at Adis wish to reflect on another successful year’s achievements and pay thanks to all those who have contributed their time and effort to guarantee the exceptional quality of our content.
We are delighted to have seen the conclusion of formalities surrounding the joint venture of Springer Science+Business Media and Nature Publishing Group, Palgrave Macmillan, Macmillan Education in early May. Substantial ground has already been made in the integration of business within the resulting Springer Nature company and we at Adis look eagerly toward the future, as the benefits of the collective expertise and capabilities of this company carry us forward.
The majority of our journals saw a rise in ISI impact factor against the previous year. Most notably, BioDrugs increased by 41 % to 2.989; the European Journal of Drug Metabolism and Pharmacokinetics increased 19 % to 1.563; CNS Drugs increased by 17 % to 5.113; Targeted Oncology increased 16 % to 4.000; Pediatric Drugs increased 15 % to 1.975; Drugs & Aging increased 13 % to 2.838; and Molecular Diagnosis & Therapy increased a further 12 % to 2.891, having already jumped 53 % in the preceding year. We hope to build upon these gains, once more, in 2016.
The Adis Book programme has grown substantially and 20 new titles will have been published over the course of the year. Over 50 further titles are currently in development with leading academics, internationally, and we continue to add more to the list. Our thanks, again, to all who have submitted these valuable proposals to date.
We offer our sincere thanks to all individuals who have reviewed or contributed articles to Drugs & Therapy Perspectives over the course of 2015. Their skill and dedication are critical to the continued publication of the journal and high standard of articles. In addition to the members of our Honorary Editorial Board, we would like to thank the following individuals who acted as reviewers for articles published in print in Drugs & Therapy Perspectives in 2015:
Darrell R. Abernethy, USA
N. Agarwal, USA
Luis Almeida, Portugal
Sabina A. Antoniu, Romania
Francisco Araujo, Spain
Mohamed Baraka, Saudi Arabia
Aygin Bayrakta-Ekincioglu, Turkey
Frederic Becq, France
R. H. Belmaker, Israel
Claudia Bernardini, Italy
Yuly Bersudsky, Israel
Chris Theo Bervoets, Belgium
Elvira Bisbe, Spain
Bernd Bokemeyer, Germany
P. Sherwood Burge, UK
David M. Burger, The Netherlands
Margarida Castel-Branco, Portugal
Natalie Cebotarenco, Moldova
Philippe Chanson, France
Barbara Claus, Belgium
Patricia K. Coyle, USA
Philippe P. Devillier, France
Jatin Dhanani, India
Ramkumar Dikshit, India
Pere Domingo, Spain
Suzanne Dunne, Ireland
Anthony Dominic D’Urzo, Canada
Mikael Eriksson, Sweden
Isabel Vitoria Figueiredo, Portugal
Mark Steven Freedman, Canada
Bharat Gajjar, India
Arthur F. Gelb, USA
David Granlund, Sweden
Lars Hagmeyer, Germany
Martina Hahn, Germany
Maria Teresa Ferreira Herdeiro, Portugal
Robert Hermann, Germany
F. Horak, Austria
R. Iacovelli, Italy
Cristoforo Incorvaia, Italy
Rob Janknegt, The Netherlands
Elmar A. Joura, Austria
Gail Judd, Canada
Siegfried Kasper, Austria
Ben Z. Katz, USA
Edward M. Kerwin, USA
Hannelore Kreckel, Germany
Michel Le Duff, France
José Lopes, Portugal
Franco Maggiolo, Italy
Marcio C. Mancini, Brazil
Sanja Mirkov, New Zealand
Joaquim Mullol, Spain
Michael T. Nurmohamed, The Netherlands
Emina Obarcanin, Bosnia and Herzegovina
Ioana Olaru, Germany
Sofia Oliveira-Martins, Portugal
Jigar Panchal, India
Tejas Patel, India
Jose Pérez-Castrillón, Spain
Marek Petras, Czech Republic
Wolfgang Raber, Austria
Isabel Maria Pires Sebastião Ramalhinho, Portugal
Dermot Ryan, UK
Helio S. Sader, USA
Ali Saklamaz, Turkey
Sandeep Saluja, India
Nathan Sandbo, USA
Amit M. Shah, India
Rima Bharatbhai Shah, India
Alpana P. Shukla, USA
Guenther G. Steger, Austria
Maysa Suyagh, Jordan
Carla Teixeira de Barros, Portugal
Paul M. Tulkens, Belgium
Themistoklis Tzotzas, Greece
Willy Marcos Valencia, USA
Jan van Lunzen, Germany
Kirsten K. Viktil, Norway
N. Von Hentig, Germany
Ulrich Wahn, Germany
Mark A. Wainberg, Canada
Jean-Pierre Zellweger, Switzerland
We hope that you have found the articles published throughout 2015 to be both interesting and informative. The editors look forward to keeping you up to date with topical issues related to rational drug use and disease management in the clinical practice setting in 2016.
With best wishes from the staff of Drugs & Therapy Perspectives and all at Adis Publications.
Rights and permissions
About this article
Cite this article
Acknowledgement to Referees. Drugs Ther Perspect 31, 407–408 (2015). https://doi.org/10.1007/s40267-015-0262-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40267-015-0262-5